CTNM
Contineum Therapeutics
CTNM
CTNM
79 hedge funds and large institutions have $338M invested in Contineum Therapeutics in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 29 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
30% more funds holding
Funds holding: 61 → 79 (+18)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
27% less call options, than puts
Call options by funds: $117K | Put options by funds: $160K
Holders
79
Holding in Top 10
4
Calls
$117K
Puts
$160K
Top Buyers
| 1 | +$27.9M | |
| 2 | +$15.3M | |
| 3 | +$12.8M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.2M |
| 5 |
CC
Commodore Capital
New York
|
+$9.31M |
Top Sellers
| 1 | -$5.69M | |
| 2 | -$229K | |
| 3 | -$228K | |
| 4 |
Squarepoint
New York
|
-$154K |
| 5 |
B
Bailard
Foster City,
California
|
-$145K |
